Porto, 20-23/04/2022.
The iToBoS project was presented at the 1st Spring Biophotonics Conference in Porto (OPORTO22), through the conference titled “Multimodal optical systems for the investigation of skin diseases”.
Porto, 20-23/04/2022.
The iToBoS project was presented at the 1st Spring Biophotonics Conference in Porto (OPORTO22), through the conference titled “Multimodal optical systems for the investigation of skin diseases”.
Barcelona, 31/03/2022.
iToBoS was presented in the framework of a course of the Academia Española de Dermatologia y Venereologia (AEDV) in Barcelona, Spain, on March 31, 2022.
Online, 31/03/2022.
iToBoS project has launched ai4pa (Artificial Intelligence For Patient Advocates) consisting in a training module oriented to patient advocates that serves as an introduction to transparent and explainable AI and its policy context.
Online, 9/03/2022.
The iToBoS 2nd Project Management Board (PMB) meeting took place on 9/03/2022 throughout video conference system with the attendance of 17 attendees.
Barcelona, 28/02 - 8/03, 2022.
iToBoS presents the objectives, challenges and expected benefits of the project at the MWC Open Innovation Challenge 2022 among a wide and multidisciplinary audience.
Barcelona, 28/02 - 3/03, 2022.
iToBoS project was presented in the 4 Years From Now (4YFN) Congress, held in Barcelona from February 28 to March 3, 2022.
Online, 9/02/2022.
The iToBoS project, its challenges and it purposes have been presented in the Green Project Expo.
Berlin, 11-13/02/2022.
iToBoS project was presented in Bootcamp21 face2face Research Strategy on February 12th, 2022.
UK, 31/01/2022.
iToBoS partner, Trilateral Research, recently contributed to a UK government call for policy advice pertaining to the risks, benefits, and ethical and legal considerations of medical data sharing.
Online, 18/01/2022.
iToBoS organized the workshop entitled “Ethical impact of the use of AI technologies for the detection of melanoma as addressed in iToBoS”.